Jeff Auxier Comments on Medtronic plc

- By Holly LaFon

Medtronic is a leader in implantable biomedical devices. Back in 2001 the stock traded at 37.5 times earnings and this past quarter traded down to 13 times earnings with a fortress balance sheet and a 7% free cash flow yield. They continue to be a leader in medical technology as their world's smallest pacemaker, Micra, accelerates US sales driving pacemaker market growth. They generate over $5 billion in free cash flow annually.

• Warning! GuruFocus has detected 7 Warning Signs with MDT. Click here to check it out.

• MDT 15-Year Financial Data

• The intrinsic value of MDT

• Peter Lynch Chart of MDT

From Jeff Auxier (Trades, Portfolio)'s Auxier Asset Management first quarter 2017 shareholder letter.
This article first appeared on GuruFocus.

• Warning! GuruFocus has detected 7 Warning Signs with MDT. Click here to check it out.

• MDT 15-Year Financial Data

• The intrinsic value of MDT

• Peter Lynch Chart of MDT